HSCA Applauds FDA for Releasing New Data to Enable Generic Competition
Washington, DC (June 19, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement applauding the U.S. Food and Drug Administration (FDA) for releasing new data to help generic drug competitors:
Click here for the full statement.
Related Posts
Comments of the Healthcare Supply Chain Association (HSCA) on FDA Request for Comments on the Importation of Prescription Drugs
March 10, 2020
Dear Commissioner Hahn: On behalf of the Healthcare Supply Chain...
HSCA Releases Third Annual Report on Value GPOs Deliver to the Healthcare Supply Chain
March 24, 2020
Washington, DC (March 24, 2020) – The Healthcare Supply Chain Association (HSCA),...
HSCA Applauds FDA for Releasing New Data to Enable Generic Competition
June 19, 2019
Washington, DC (June 19, 2019) – Healthcare Supply Chain Association (HSCA)...
Joint Letter of Support for the MEDS Act
November 5, 2019
Dear Senator Collins and Senator Smith, The undersigned organizations are...